Maxigen Biotech Inc. reported consolidated revenue results for the month and year-to-date ended July 2022. For the month, the company reported net revenue of approximately TWD 46.993 million, an increase of 33.47% over the same period in 2021.

For the year-to-date, the company reported net revenue totaled TWD 324.509 million, an increase of 21.41% compared to the TWD 267.291 million for the same period in 2021.